Jump to content

Glaucoma And Cannabis


Recommended Posts


Anuj Chauhan, Ph.D., who headed the research team, explained that glaucoma is second only to cataracts as the leading cause of vision loss and blindness in the world. It affects almost 67 million people.


Eye drops that relieve the abnormal build-up of pressure inside the eye that occurs in glaucoma, are a mainstay treatment.

"The problem is within about two to five minutes of putting drops in the eye, tears carry the drug away and it doesn't reach the targeted tissue," said Chauhan, who is with the University of Florida in Gainesville. "Much of the medicine gets absorbed into the bloodstream, which carries it throughout the body where it could cause side effects. Only about one to five percent of drugs in eye drops actually reach the cornea of the eye."




this was on the radio today. not sure why it was talking about a contact lens from 2010, but maybe some news about it has updated.


updated glaucoma research 5-2013



Cannabinoids and glaucoma


mentions that THC and CBD decreases IOP

(two different chemicals in the same plant can do the same medical benefit! how amazing is that?)


reading scientific papers like this is so horrible when you read what they tried in the past. mixing medications with mineral oil so it would be more liquid. they report mineral oil causes eye irritation. thats why the mineral oil bottle has that warning label on it about not getting any in your eye, geniuses!


researching the Glaucoma medicine Canasol made in jamaica


unfortunately, one of the doctors who worked on creating it passed away last year.



West has received national and international acclaim for his development of the drug Canasol, as a treatment for glaucoma, for which achievement he was awarded the Order of Merit from the Government.


cant find any updated information on canasol.




Throughout his academic career, he was particularly interested in research involving medicinal herbs. This led to the development of the drugs Canasol and Asmasol from marijuana for the treatment of glaucoma and asthma, respectively. His students are all familiar with the inspiration that lead to the development of Canasol. On his return from England, he bought fishing boats and the fishermen on his boats told him that fishing at nights was facilitated by the improved vision from smoking marijuana and so Professor West sought to identify the cause of this observation. For this pioneering work he was awarded the Order of Merit in 1987 from the Government of Jamaica. He was also awarded the Gold Musgrave Medal in 1994 from the Institute of Jamaica for his pioneering work in the development of Canasol.

He was awarded the FAO/United Nations/Jamaica World Food Day "Biodiversity Award" for contribution to Ophthalmic Medicine in Jamaica, The Berger Paint Award for Natural Sciences and The Centenary Medal from the Institute of Jamaica for outstanding contribution to cultural development in Jamaica in the field of Natural Science. He published many academic papers, focussed on research in diabetes, cancer, glaucoma and respiratory function.



sept 2 - 2013 - School of marijuana - Research facility to be established



dec 4 2013 - Jamaica's first medical ganja company launched


MediCanja will undertake pioneering research and product development using the medicinal compounds called the CBDs – the non-psychoactive compounds in ganja.



Link to comment
Share on other sites

  • 4 months later...
  • 1 year later...

Glaucoma is an issue which impacts the eyes of a individual. The optic nerves become damaged over time. This is a problem that once sets in the eyes of a individual result in permanent damage in the vision of the impacted eye. Glaucoma doesn't snatch vision right away; it is a gradual process as a result the name "silent thief of sight" has been related to Glaucoma.

Link to comment
Share on other sites

The much-prevalent glaucoma can be avoided and also taken care of utilizing medical cannabis, which in turn reduces force inside the eyeball and slowed the progression of the sickness, and thus preventing blindness.

I would like to see studies of cannabis users who avoid glaucoma, that would be awesome!

I know people who do reduce their ocular pressure with our herb, but never thought about prevention of the disease.

I suspect I will never contract it! :)

Link to comment
Share on other sites

  • 3 years later...

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Similar Content

    • By RobertReny
      According to the new law passed by the Colorado government doctors can prescribe medical marijuana for patients suffering from cancer, HIV and AIDS, glaucoma, PTSD or other chronic medical condition that causes, nausea, severe pain, and seizures. The new law includes all medical conditions in which opioids could be recommended.
    • By djziddi
      My mom has a strange type of glaucoma. She said it is Uvietis caused by glaucoma. And it has to do something about the pressure of her eye being too low or high. (Not sure which)
      And she asked her Dr. about medical marijuana and the doctor said that it might make it worse. Im not sure if her Dr is lieing to her or not..
      Anyone know about this?
    • By t-pain

      Some cannabinoid agonists (WIN 55212-2, anandamide) have demonstrated, in experimental studies, to act as ideal drugs in the management of glaucoma, as they have been shown to have good tolerability after topical application, efficiently reduce intraocular pressure, and behave as neuroprotectors on retinal ganglion cells. Further studies as regards the safety and clinical assays must be carried out in order to examine the effectiveness of these drugs for the treatment of glaucoma in our daily clinical practice.
      aha, finally something tells you what they made eye drops from. of course this is a spanish>english machine translated scientific document , so there maybe errors and you should translate the page yourself before putting anything in your eye.
      Topical application of cannabinoids

      Due to the high lipid solubility, and the need to employ lipophilic products for proper dissolution, many vehicles have been tested, such as ethanol, dimethyl sulfoxide, polivinilpyrrolidone, Tween 80, Cremophor, emulphor, bovine serum albumin (BSA), 2-hydroxypropyl -β-ciclodextrino, and currently, it has been popularized Tocrisolve employing TM 67. the TM is a registered Tocrisolve preparation consisting of a vehicle designed for lipophilic compounds, such as cannabinoid and vanilloid agonists. The Tocrisolve TM consists of soybean oil in a ratio of 1:4 with water and is emulsified with the copolymer pluronic F68. Allows dissolve WIN 55212-2 to a concentration of 2%. On the other hand does not require the use of ethanol to promote your solution and has demonstrated a sustained ocular penetration agonist WIN 55212-2 dissolved therein applied topically after 68.

      The Δ9-THC, dissolved in mineral oil, was shown to reduce the intraocular pressure equal to or higher than that obtained by pilocarpine (52% reduction), with a more prolonged effect 38,68. This hypotensive effect has been reproduced in other studies with different cannabinoids ( Table 2 ).
      Topical application of Δ9-THC, CBN and CBD has been associated with mydriasis, conjunctival hyperemia, chemosis, severe cases of corneal opacification and neurotoxicity 70. Other ocular side effects associated with systemic administration routes are cannabinoids decrease in tear production, diplopia, accommodation disturbances, photophobia, nystagmus and blepharospasm 7,10,66,70.
      The use of new solvents such as Tocrisolve TM and the 2-hydroxypropyl-β-ciclodextrino allowed correct cannabinoies dissolving and preparing solutions suitable for ocular application. Although the results to date are promising for application in the field of glaucoma, more safety studies and clinical trials are still necessary to examine the usefulness of these compounds in the treatment of glaucoma in our clinic daily.
    • By t-pain
      After ten years of continuous and diligent research, pharmacologist,
      Professor Manley West and ophthalmologist, Dr. Albert Lockhart
      developed an eye drop, Canasol, specifically to treat the eye disease,
      glaucoma. Glaucoma is estimated to affect 3% of the Jamaican population
      and causes pain, visual disturbances and even blindness.

      The drug was an important breakthrough, because it is derived from ganja,
      Cannabis sativa, and was the first eye medication in the Caribbean to be
      developed at UWI, Mona for this disease. Canasol has an important benefit
      since it does not induce the negative side effects that are associated with
      synthetic glaucoma therapies.


      Professor West became interested in studying the ganja plant because he
      had observed that country folk who used an eye wash made up of ganja in
      water, always reported to him that it made them see better. The fishermen
      who drank ganja ‘tea’ made the same claim and further claimed that their
      vision at night was also better.

      Dr. Albert Lockhart noted that his Rastafarian patients who used ganja had
      a low incidence of glaucoma. More recently, he discovered that the eye
      drop, Canasol, improves the integrity of the optic nerve, the nerve which
      causes us to see, thus preventing blindness.

      As the researchers further investigated other properties of ganja, they dis-
      covered its effectiveness against motion sickness. They developed the drug
      Canavert, which specifically stabilizes the part of the brain that controls
      motion sickness, thereby inhibiting vomiting and nausea that accompanies
      this condition. However, the drug has not yet been prepared in commercial

      In the early 1990s, Professor West developed the drug, Asmasol, to treat
      asthma, colds and the flu. The doctors now using this drug, report that
      they prescribe it for children as well as adults, and that it is effective during
      both the early and the late phases of the condition. Asmasol is a derivative
      of ganja and is available in pharmacies throughout the Caribbean.

      Professor Manley West is an emeritus Professor of Pharmacology in the
      Faculty of Medical Sciences, UWI, Mona and the recipient of the Order of
      Merit from the Government of Jamaica and the Gold Musgrave Medal from
      the Institute of Jamaica for the development of Canasol. He also received
      the Order of Merit from the Government of Canada for cardiovascular research.

      Dr. Albert Lockhart received the Order of Merit from the Government of
      Jamaica and the Gold Musgrave Medal from the Institute of Jamaica for the
      development of Canasol.

    • By t-pain
      who says marijuana does not work to reduce IOP in glaucoma?
      even orally:
      This uncontrolled, unmasked, nonrandomized, prospec-tive study does not permit definitive conclusions about the
      efficacy or toxicity of cannabinoids in the treatment of
      glaucoma. There is an impression from this study that
      treatment with oral THC lowered IOP in this group of
      patients with end-stage open-angle glaucoma, but the
      development of tolerance and the coexistence of signifi-cant systemic toxicity limited the potential usefulness of
      this treatment. It was particularly impressive to the inves-tigators that throughout the study there was no observed
      tendency for either the physicians or the patients to abuse
      their access to cannabinoid derivatives. Furthermore, both
      the patients and ophthalmologists greatly appreciated the
      opportunity to participate in a study that gave them legal
      access to cannabinoids as a last-resort treatment for end-stage glaucoma unresponsive to conventional treatments.
      i do not understand why they talk about limited usefulness, the conventional medications had failed in these test subjects. it has tremendous usefulness for subjects where other medications do not work.
      i do not understand why they talk about toxicity to oral thc.
      All subjects experienced side effects during their
      treatment with THC during this study (Table III). The
      most commonly described toxic effects were dry mouth,
      sleepiness, dizziness, depression, and confusion; these
      effects were the same as those reported by other investi-gators.
      18,19Although many of the side effects were consid-ered mild and were of little concern to subjects, other effects were very significant.

  • Create New...